Showing results (91-100 of 135) with videos related to
Sort By:
Pageof 14
Carcinogenesis|December 11, 1999
Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in ratsR K Wali, S Skarosi, J Hart, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosoureaS N Kurpad, M E Dolan, R E McLendon, et al.The Pharmacogenomics Journal|August 17, 2011
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populationsH E Wheeler, E R Gamazon, A L Stark, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primatesL Long, S L Berg, S K Roy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysisE E Vokes, M E Dolan, S Krishnasamy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agentsM E Dolan, B L McRae, E Ferries-Rowe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancerE E Vokes, R Mick, M S Kies, et al.Metabolism: Clinical and Experimental|July 1, 1994
Independent and combined actions of interleukin-1 beta, tumor necrosis factor alpha, and glucagon on amino acid metabolism in the isolated perfused rat liverJ P De Bandt, S K Lim, F Plassart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograftV J Patel, G B Elion, P J Houghton, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Repair of O-alkylpyrimidines in mammalian cells: a present consensusT P Brent, M E Dolan, H Fraenkel-Conrat, et al.Pageof 14